NEOPLASMS, COLORECTAL
Clinical trials for NEOPLASMS, COLORECTAL explained in plain language.
Never miss a new study
Get alerted when new NEOPLASMS, COLORECTAL trials appear
Sign up with your email to follow new studies for NEOPLASMS, COLORECTAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug targets hard-to-treat cancers in major clinical trial
Disease control OngoingThis study tests a new drug called 9-ING-41, given alone or with chemotherapy, in adults with advanced cancers that have stopped responding to standard treatments. The goal is to see if the drug is safe and can help control the cancer. About 350 people with various cancer types, …
Matched conditions: NEOPLASMS, COLORECTAL
Phase: PHASE2 • Sponsor: Actuate Therapeutics Inc. • Aim: Disease control
Last updated May 26, 2026 08:39 UTC
-
New pill takes aim at aggressive tumors with genetic flaw
Disease control OngoingThis study tests an experimental pill (GSK4418959) in adults with advanced solid tumors that have specific genetic changes (dMMR or MSI-H). The drug targets a DNA repair protein to try to shrink tumors. The trial will check safety, side effects, and how well the drug works alone …
Matched conditions: NEOPLASMS, COLORECTAL
Phase: PHASE1, PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated May 26, 2026 08:34 UTC
-
New combo therapy targets Hard-to-Treat cancers with KRAS mutation
Disease control OngoingThis study is for people with advanced solid tumors (like lung or colorectal cancer) that have a specific genetic change called KRAS G12C. It tests a new drug, JDQ443, combined with other treatments to see if they are safe and can shrink tumors. About 74 adults will take part. Th…
Matched conditions: NEOPLASMS, COLORECTAL
Phase: PHASE1, PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 19, 2026 11:59 UTC